Correlation Between Viking Therapeutics and Taysha Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Taysha Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Taysha Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Taysha Gene Therapies, you can compare the effects of market volatilities on Viking Therapeutics and Taysha Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Taysha Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Taysha Gene.

Diversification Opportunities for Viking Therapeutics and Taysha Gene

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viking and Taysha is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Taysha Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taysha Gene Therapies and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Taysha Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taysha Gene Therapies has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Taysha Gene go up and down completely randomly.

Pair Corralation between Viking Therapeutics and Taysha Gene

Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the Taysha Gene. But the stock apears to be less risky and, when comparing its historical volatility, Viking Therapeutics is 3.14 times less risky than Taysha Gene. The stock trades about -0.23 of its potential returns per unit of risk. The Taysha Gene Therapies is currently generating about 0.38 of returns per unit of risk over similar time horizon. If you would invest  134.00  in Taysha Gene Therapies on September 4, 2024 and sell it today you would earn a total of  174.00  from holding Taysha Gene Therapies or generate 129.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viking Therapeutics  vs.  Taysha Gene Therapies

 Performance 
       Timeline  
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Viking Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Taysha Gene Therapies 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Taysha Gene Therapies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Taysha Gene sustained solid returns over the last few months and may actually be approaching a breakup point.

Viking Therapeutics and Taysha Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viking Therapeutics and Taysha Gene

The main advantage of trading using opposite Viking Therapeutics and Taysha Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Taysha Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taysha Gene will offset losses from the drop in Taysha Gene's long position.
The idea behind Viking Therapeutics and Taysha Gene Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance